Literature DB >> 17309504

Adherence and anticarcinogenic effects of Bacillus polyfermenticus SCD in the large intestine.

N-K Lee1, J-S Park, E Park, H-D Paik.   

Abstract

AIMS: To investigate the probiotic properties of Bacillus polyfermenticus SCD such as their adherence to Caco-2 cells and anticarcinogenic effects on human colon cancer cells and rat colon cancer carcinogenesis. METHODS AND
RESULTS: The cell surface hydrophobicity and cell agglutination of B. polyfermenticus SCD was 64.04 +/- 1.25% and 297.3 +/- 8.7 mg ml(-1), respectively. This strain was strongly adherent to Caco-2 cells. Bacillus polyfermenticus SCD was also found to inhibit the growth of colon cancer cells in a dose-dependent manner as detected by the MTT assay. After 10 weeks of B. polyfermenticus SCD supplementation with 3 x 10(6) CFU day(-1) in F344 male rats, dimethylhydrazine-induced aberrant crypts and preneoplastic lesions decreased by 40% compared with the control rats.
CONCLUSIONS: Bacillus polyfermenticus SCD has strong adherent properties in the colon, and anticarcinogenic effects in vitro and in vivo. SIGNIFICANCE AND IMPACT OF THE STUDY: These new findings on the characteristics of B. polyfermenticus SCD will be valuable in the evaluation of this commercial probiotic. Also, B. polyfermenticus SCD can be useful for the inhibition of colon cancer cells as an ingredient of medicinal foods or new drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17309504     DOI: 10.1111/j.1472-765X.2006.02078.x

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  15 in total

1.  The angiogenic effect of probiotic Bacillus polyfermenticus on human intestinal microvascular endothelial cells is mediated by IL-8.

Authors:  Eunok Im; Yoon Jeong Choi; Cho Hee Kim; Claudio Fiocchi; Charalabos Pothoulakis; Sang Hoon Rhee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11       Impact factor: 4.052

2.  The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition.

Authors:  Elise L Ma; Yoon Jeong Choi; Jinyoung Choi; Charalabos Pothoulakis; Sang Hoon Rhee; Eunok Im
Journal:  Int J Cancer       Date:  2010-08-15       Impact factor: 7.396

Review 3.  Gut microbiota and probiotics in colon tumorigenesis.

Authors:  Yuanmin Zhu; T Michelle Luo; Christian Jobin; Howard A Young
Journal:  Cancer Lett       Date:  2011-06-24       Impact factor: 8.679

Review 4.  The interrelationships of the gut microbiome and inflammation in colorectal carcinogenesis.

Authors:  Margaret Cho; Janell Carter; Saul Harari; Zhiheng Pei
Journal:  Clin Lab Med       Date:  2014-09-15       Impact factor: 1.935

5.  Characterization of Lactobacillus plantarum Lb41, an isolate from kimchi and its application as a probiotic in cottage cheese.

Authors:  Eun Bi Jeon; Sung-Ho Son; Renda Kankanamge Chaturika Jeewanthi; Na-Kyoung Lee; Hyun-Dong Paik
Journal:  Food Sci Biotechnol       Date:  2016-08-31       Impact factor: 2.391

Review 6.  Vitamin D/VDR, Probiotics, and Gastrointestinal Diseases.

Authors:  Mei Shang; Jun Sun
Journal:  Curr Med Chem       Date:  2017       Impact factor: 4.530

Review 7.  The role of gut microbiota in the pathogenesis of colorectal cancer.

Authors:  Qingchao Zhu; Renyuan Gao; Wen Wu; Huanlong Qin
Journal:  Tumour Biol       Date:  2013-02-10

Review 8.  Probiotics against neoplastic transformation of gastric mucosa: effects on cell proliferation and polyamine metabolism.

Authors:  Francesco Russo; Michele Linsalata; Antonella Orlando
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

Review 9.  Intestinal microbiota, probiotics and human gastrointestinal cancers.

Authors:  Antonella Orlando; Francesco Russo
Journal:  J Gastrointest Cancer       Date:  2013-06

Review 10.  Emerging prospects of macro- and microalgae as prebiotic.

Authors:  Anil Kumar Patel; Reeta Rani Singhania; Mukesh Kumar Awasthi; Sunita Varjani; Shashi Kant Bhatia; Mei-Ling Tsai; Shu-Ling Hsieh; Chiu-Wen Chen; Cheng-Di Dong
Journal:  Microb Cell Fact       Date:  2021-06-05       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.